Drugs & Targets CHMP issues positive opinion on Talzenna for Talzenna in breast cancer indication May 03, 2019Vol.45 No.18
Drugs & Targets CHMP issues positive opinion for Libtayo for squamous cell carcinoma May 03, 2019Vol.45 No.18
Drugs & Targets CHMP issues positive opinion for Lynparza in maintenance therapy in ovarian cancer May 03, 2019Vol.45 No.18
Drugs & Targets Caris to perform genomic profiling for Hoosier Cancer Research Network Bladder Cancer Study May 03, 2019Vol.45 No.18
Drugs & TargetsFree FDA approves Balversa for urothelial carcinoma with FGFR genetic alterations April 19, 2019Vol.45 No.16
Drugs & TargetsFree FDA expands pembrolizumab indication for first-line treatment of NSCLC April 19, 2019Vol.45 No.16
